Evidence map›Paper›PMID 25571973›Full record

ArticleCell death and differentiation2015

p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.

R Fernandez-Alonso, M Martin-Lopez, L Gonzalez-Cano, S Garcia, F Castrillo, I Diez-Prieto, A Fernandez-Corona, M E Lorenzo-Marcos, X Li, L Claesson-Welsh and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. p53 Family in Resistance to Targeted Therapy of Melanoma.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. p73 as a Tissue Architect.Frontiers in cell and developmental biology · 2021
    Review
  14. Expression ofJournal of ophthalmology · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Clinical implications of the deregulated TP73 isoforms expression in cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

R Fernandez-AlonsoInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
M Martin-LopezInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
L Gonzalez-CanoInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
S GarciaInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
F CastrilloInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
I Diez-Prieto1] Instituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain [2] Departamento de Medicina, Cirugia y Anatomia Veterinaria, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
A Fernandez-Corona1] Instituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain [2] Complejo Hospitalario de Leon, Altos de Nava s/n, 24071 Leon, Spain.
M E Lorenzo-Marcos1] Instituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain [2] Complejo Hospitalario de Leon, Altos de Nava s/n, 24071 Leon, Spain.
X LiRudbeck Laboratory and Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Dag Hammarksjöldsv 20, 751 85 Uppsala, Sweden.
L Claesson-WelshRudbeck Laboratory and Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Dag Hammarksjöldsv 20, 751 85 Uppsala, Sweden.
M M MarquesInstituto de Desarrollo Ganadero, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
M C MarinInstituto de Biomedicina (IBIOMED), Departamento de Biologia Molecular, University of Leon, Campus de Vegazana, 24071 Leon, Spain.
Universidad de León · ESUppsala University · SEHospital de León · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasculogenesis, the establishment of the vascular plexus and angiogenesis, branching of new vessels from the preexisting vasculature, involves coordinated endothelial differentiation, proliferation and migration. Disturbances in these coordinated processes may accompany diseases such as cancer. We hypothesized that the p53 family member p73, which regulates cell differentiation in several contexts, may be important in vascular development. We demonstrate that p73 deficiency perturbed vascular development in the mouse retina, decreasing vascular branching, density and stability. Furthermore, p73 deficiency could affect non endothelial cells (ECs) resulting in reduced in vivo proangiogenic milieu. Moreover, p73 functional inhibition, as well as p73 deficiency, hindered vessel sprouting, tubulogenesis and the assembly of vascular structures in mouse embryonic stem cell and induced pluripotent stem cell cultures. Therefore, p73 is necessary for EC biology and vasculogenesis and, in particular, that DNp73 regulates EC migration and tube formation capacity by regulation of expression of pro-angiogenic factors such as transforming growth factor-β and vascular endothelial growth factors. DNp73 expression is upregulated in the tumor environment, resulting in enhanced angiogenic potential of B16-F10 melanoma cells. Our results demonstrate, by the first time, that differential p73-isoform regulation is necessary for physiological vasculogenesis and angiogenesis and DNp73 overexpression becomes a positive advantage for tumor progression due to its pro-angiogenic capacity.

Indexed as

AnimalsCell DifferentiationDNA-Binding ProteinsEndothelial CellsHuman Umbilical Vein Endothelial CellsImmunohistochemistryMiceMice, Inbred C57BLNuclear ProteinsReal-Time Polymerase Chain ReactionRetinaRNA, Small InterferingSignal TransductionTransforming Growth Factor betaTumor Protein p73Tumor Suppressor ProteinsDNA-Binding ProteinsNuclear ProteinsRNA, Small InterferingTP73 protein, humanTransforming Growth Factor betaTrp73 protein, mouseTumor Protein p73Tumor Suppressor ProteinsVascular Endothelial Growth Factor A

Identifiers

PMID25571973
PMCPMC4495354
OpenAlexW2167209509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.